Immunotherapy Blog

Webinar - GMP Raw Materials for Cell Therapy: What, When, How?

Join our panel of experts Jean Stanton (J&J), John Tomtishen (Novartis), Dr. Sadik Kassim (Mustang Bio), and Dr. Diane Wotta (Bio-Techne) as they discuss: what GMP really means in the context of raw materials and ancillary reagents; the quality of raw materials required along the commercialization pathway; when to start using GMP materials; and the current regulatory landscape.

Webinar Short: B7-related Butryophilins as Immune Modulators

A short description of Butyrophilin proteins produced by R&D Systems. These B7-related proteins may be checkpoint targets.

Butyrophilin Products

Recorded December 22, 2017

A Role for VSIG-3/VISTA Signaling in Acquired Resistance to Anti-PD-1 Therapy?

t-cell and tumor cell